PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18322468-0	2009	Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine.	Fluvoxamine	77-88	solute carrier family 6 member 4	Rattus norvegicus	52-73	
22225849-2	2012	Previously, we reported that acute systemic treatment with estradiol or progesterone blocked the ability of the selective serotonin reuptake inhibitor, fluvoxamine, to inhibit serotonin transporter function in ovariectomized rats.	Fluvoxamine	152-163	solute carrier family 6 member 4	Rattus norvegicus	176-197	
21371073-2	2011	The serotonin transporter (SERT) handles serotonin (5-hydroxytryptamine (5-HT)) and is blocked by the antidepressant SERT inhibitors fluoxetine and fluvoxamine.	Fluvoxamine	148-159	solute carrier family 6 member 4	Rattus norvegicus	4-25	
21371073-2	2011	The serotonin transporter (SERT) handles serotonin (5-hydroxytryptamine (5-HT)) and is blocked by the antidepressant SERT inhibitors fluoxetine and fluvoxamine.	Fluvoxamine	148-159	solute carrier family 6 member 4	Rattus norvegicus	27-31	
21371073-2	2011	The serotonin transporter (SERT) handles serotonin (5-hydroxytryptamine (5-HT)) and is blocked by the antidepressant SERT inhibitors fluoxetine and fluvoxamine.	Fluvoxamine	148-159	solute carrier family 6 member 4	Rattus norvegicus	117-121	
21371073-10	2011	In in vitro experiments, SERT affected the contractility of aortas from female rats, as evidenced by an eightfold increase in potency of 5-HT in fluvoxamine (1 mumol/L)-incubated WT aortas compared with control.	Fluvoxamine	145-156	solute carrier family 6 member 4	Rattus norvegicus	25-29	
18493251-1	2008	BACKGROUND AND PURPOSE: The pharmacokinetic-pharmacodynamic (PK-PD) correlation of fluvoxamine 5-HT transporter (SERT) occupancy was determined in rat frontal cortex ex vivo.	Fluvoxamine	83-94	solute carrier family 6 member 4	Rattus norvegicus	113-117	
15167270-6	2004	5-HT-induced contraction of normal aorta was potentiated by the 5-HTT inhibitor fluvoxamine.	Fluvoxamine	80-91	solute carrier family 6 member 4	Rattus norvegicus	64-69	
15167270-7	2004	A change in arterial 5-HTT function occurs in deoxycorticosterone (DOCA)-salt hypertension as the potency and threshold of 5-HT in contracting aorta from the DOCA-salt rat was increased by fluoxetine and fluvoxamine (1 micromol/L; DOCA fluvoxamine -log EC50 [mol/L] = 6.85 +/- 0.08, DOCA-control = 6.44 +/- 0.08); expression of transporter was significantly increased in aorta of DOCA salt rats (145% Sham).	Fluvoxamine	204-215	solute carrier family 6 member 4	Rattus norvegicus	21-26	
9669506-2	1998	The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter.	Fluvoxamine	65-76	solute carrier family 6 member 4	Rattus norvegicus	111-127	
9871099-3	1998	While binding of [123I]nor-beta-CIT in the hypothalamus was blocked significantly by fluvoxamine (a selective serotonin transporter blocker) but not by GBR12,909 (a selective dopamine transporter blocker), the opposite was observed in the striatum.	Fluvoxamine	85-96	solute carrier family 6 member 4	Rattus norvegicus	110-131